Ken Awuondo
Overview
Explore the profile of Ken Awuondo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
425
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gitaka J, Ogwang C, Ngari M, Akoo P, Olotu A, Kerubo C, et al.
PLoS One
. 2017 May;
12(5):e0177382.
PMID: 28493930
Reference intervals for clinical laboratory parameters are important for assessing eligibility, toxicity grading and management of adverse events in clinical trials. Nonetheless, haematological and biochemical parameters used for clinical trials...
2.
Mogeni P, Williams T, Fegan G, Nyundo C, Bauni E, Mwai K, et al.
PLoS Med
. 2016 Jun;
13(6):e1002047.
PMID: 27352303
Background: Encouraging progress has been seen with reductions in Plasmodium falciparum malaria transmission in some parts of Africa. Reduced transmission might lead to increasing susceptibility to malaria among older children...
3.
Berkley J, Ngari M, Thitiri J, Mwalekwa L, Timbwa M, Hamid F, et al.
Lancet Glob Health
. 2016 Jun;
4(7):e464-73.
PMID: 27265353
Background: Children with complicated severe acute malnutrition (SAM) have a greatly increased risk of mortality from infections while in hospital and after discharge. In HIV-infected children, mortality and admission to...
4.
Hodgson S, Juma E, Salim A, Magiri C, Njenga D, Molyneux S, et al.
Malar J
. 2015 May;
14:182.
PMID: 25927522
Background: Controlled human malaria infection (CHMI) studies, in which healthy volunteers are infected with Plasmodium falciparum to assess the efficacy of novel malaria vaccines and drugs, have become a vital...
5.
Hodgson S, Juma E, Salim A, Magiri C, Kimani D, Njenga D, et al.
Front Microbiol
. 2015 Jan;
5:686.
PMID: 25566206
Background: Controlled human malaria infection (CHMI) studies are a vital tool to accelerate vaccine and drug development. As CHMI trials are performed in a controlled environment, they allow unprecedented, detailed...
6.
Gitonga C, Kihara J, Njenga S, Awuondo K, Noor A, Snow R, et al.
Am J Trop Med Hyg
. 2012 Oct;
87(6):1004-1011.
PMID: 23091194
Malaria rapid diagnostic tests (RDTs) are known to yield false-positive results, and their use in epidemiologic surveys will overestimate infection prevalence and potentially hinder efficient targeting of interventions. To examine...
7.
Klein Klouwenberg P, Sasi P, Bashraheil M, Awuondo K, Bonten M, Berkley J, et al.
PLoS One
. 2011 Jul;
6(7):e21013.
PMID: 21754982
Background: In sub-Saharan Africa, Plasmodium falciparum and hepatitis A (HAV) infections are common, especially in children. Co-infections with these two pathogens may therefore occur, but it is unknown if temporal...
8.
Nyiro J, Sanders E, Ngetsa C, Wale S, Awuondo K, Bukusi E, et al.
BMC Infect Dis
. 2011 Jun;
11:155.
PMID: 21627803
Background: Herpes Simplex Virus type 2 (HSV-2) has public health importance as a leading cause of genital ulcers, a co-factor in HIV-1 acquisition and transmission and as a cause of...
9.
Sasi P, Abdulrahaman A, Mwai L, Muriithi S, Straimer J, Schieck E, et al.
J Infect Dis
. 2009 May;
199(11):1575-82.
PMID: 19405863
In light of reports of increasing resistance of parasites to amodiaquine in African countries in which Plasmodium falciparum is endemic as well as the paucity of recent in vitro sensitivity...
10.
Karita E, Ketter N, Price M, Kayitenkore K, Kaleebu P, Nanvubya A, et al.
PLoS One
. 2009 Feb;
4(2):e4401.
PMID: 19197365
Background: Clinical laboratory reference intervals have not been established in many African countries, and non-local intervals are commonly used in clinical trials to screen and monitor adverse events (AEs) among...